NO160360C - Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.

Info

Publication number
NO160360C
NO160360C NO845147A NO845147A NO160360C NO 160360 C NO160360 C NO 160360C NO 845147 A NO845147 A NO 845147A NO 845147 A NO845147 A NO 845147A NO 160360 C NO160360 C NO 160360C
Authority
NO
Norway
Prior art keywords
optionally substituted
substituted phenyl
lower alkyl
alkyl
naftalen
Prior art date
Application number
NO845147A
Other languages
English (en)
Other versions
NO160360B (no
NO845147L (no
Inventor
Gordon H Jones
Michael C Venuti
John M Young
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO845147L publication Critical patent/NO845147L/no
Publication of NO160360B publication Critical patent/NO160360B/no
Publication of NO160360C publication Critical patent/NO160360C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C07C205/46Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group the carbon skeleton containing carbon atoms of quinone rings
    • C07C205/47Anthraquinones containing nitro groups
    • C07C205/48Anthraquinones containing nitro groups the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/02Preparation of quinones by oxidation giving rise to quinoid structures
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/24Quinones containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/26Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Multiple-Way Valves (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Organic Insulating Materials (AREA)
  • Luminescent Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO845147A 1983-12-22 1984-12-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. NO160360C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/564,155 US4593120A (en) 1982-10-27 1983-12-22 Naphthalene anti-psoriatic agents

Publications (3)

Publication Number Publication Date
NO845147L NO845147L (no) 1985-06-24
NO160360B NO160360B (no) 1989-01-02
NO160360C true NO160360C (no) 1989-04-12

Family

ID=24253366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO845147A NO160360C (no) 1983-12-22 1984-12-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.

Country Status (15)

Country Link
US (1) US4593120A (no)
EP (1) EP0146145B1 (no)
JP (1) JPS60156642A (no)
KR (1) KR850004574A (no)
AT (1) ATE45877T1 (no)
AU (1) AU580277B2 (no)
DE (1) DE3479563D1 (no)
DK (1) DK617284A (no)
ES (1) ES8600730A1 (no)
FI (1) FI845047L (no)
HU (1) HU195471B (no)
IL (1) IL73878A0 (no)
NO (1) NO160360C (no)
NZ (1) NZ210666A (no)
ZA (1) ZA849959B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466981A (en) * 1982-10-27 1984-08-21 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DK35885A (da) * 1984-01-27 1985-07-28 Syntex Inc Naphthalenderivater
US5026759A (en) * 1985-05-08 1991-06-25 Du Pont Merck Pharmaceutical 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
ZA863425B (en) * 1985-05-08 1988-01-27 Du Pont 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
US4833164A (en) * 1985-05-08 1989-05-23 E. I. Du Pont De Nemours And Company 2-substituted-1-naphthols, pharmaceutical compositions of, and their use as 5-lipoxygenase inhibitors
US4792556A (en) * 1985-09-09 1988-12-20 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
JPS6284046A (ja) * 1985-09-09 1987-04-17 シンテツクス(ユ−・エス・エイ)インコ−ポレイテツド ナフタレン系抗乾癬剤
FI881065A (fi) * 1987-03-09 1988-09-10 Syntex Inc Foerfarande foer framstaellning av naftalenfoereningar anvaendbara vid behandling av psoriasis.
US4786652A (en) * 1987-03-09 1988-11-22 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
US5134161A (en) * 1987-03-09 1992-07-28 Syntex (U.S.A.) Inc. Method for treating disease states in mammals with naphthalene lipoxygenase-inhibiting agents
US4882339A (en) * 1987-07-10 1989-11-21 Ciba-Geigy Corporation 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals
US5242946A (en) * 1988-10-27 1993-09-07 Bio-Mega, Inc. Treating herpes Viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466981A (en) * 1982-10-27 1984-08-21 Syntex (U.S.A.) Inc. Naphthalene anti-psoriatic agents
DK35885A (da) * 1984-01-27 1985-07-28 Syntex Inc Naphthalenderivater
JPH0520420A (ja) * 1991-07-12 1993-01-29 Brother Ind Ltd 図形処理装置

Also Published As

Publication number Publication date
EP0146145B1 (en) 1989-08-30
HU195471B (en) 1988-05-30
EP0146145A2 (en) 1985-06-26
ZA849959B (en) 1986-08-27
FI845047A0 (fi) 1984-12-20
NO160360B (no) 1989-01-02
KR850004574A (ko) 1985-07-25
FI845047L (fi) 1985-06-23
JPS60156642A (ja) 1985-08-16
ES538903A0 (es) 1985-11-01
ATE45877T1 (de) 1989-09-15
DK617284D0 (da) 1984-12-20
ES8600730A1 (es) 1985-11-01
NO845147L (no) 1985-06-24
EP0146145A3 (en) 1986-04-16
NZ210666A (en) 1988-06-30
AU3711984A (en) 1985-07-04
DK617284A (da) 1985-06-23
IL73878A0 (en) 1985-03-31
AU580277B2 (en) 1989-01-12
HUT36079A (en) 1985-08-28
DE3479563D1 (en) 1989-10-05
US4593120A (en) 1986-06-03

Similar Documents

Publication Publication Date Title
NO833900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalenderivater
NO160360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
ES539866A0 (es) Procedimiento para la preparacion de compuestos antipsoria- ticos naftalenicos
DK428686A (da) Naphthalenderivater